Bought
Maintained
Sold
Other funds holding MEDP
WA
Aviva's MEDP Position: Q2 2026 in Review
Aviva increased its Medpace (MEDP) stake by 34% in Q2 2026, buying an estimated $156K and bringing the position to 1,322 shares worth $700K. The position accounts for ﹤0.01% of the portfolio, ranked #661.
Aviva first reported a position in MEDP in Q3 2021 and has held it in 20 quarters since. The position peaked at $2.63M in Q4 2021. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Aviva held 1,322 shares of Medpace worth $700K as of Q2 2026.
- Aviva bought 339 Medpace shares in Q2 2026, an estimated $156K.
- Medpace made up ﹤0.01% of Aviva's portfolio in Q2 2026, its #661 holding.
- Aviva first reported a position in Medpace in Q3 2021 and has held it in 20 quarters since.
- Aviva's Medpace position peaked at $2.63M in Q4 2021.
- 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.